Core Laboratories N.V. with ticker code (CLB) now have 9 analysts in total covering the stock. The consensus rating is ‘Hold’. The target price ranges between 32 and 13 with a mean TP of 20.89. Now with the previous closing price of 22.97 this would imply there is a potential downside of -9.1%. The 50 day MA is 17.57 and the 200 day MA is 22.69. The market capitalisation for the company is $1,042m. Find out more information at: https://www.corelab.com
The potential market cap would be $948m based on the market concensus.
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients’ reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.
